comparemela.com
  1. Home
  2. Live Updates
  3. Refractory Epilepsy Special Access Scheme - Breaking News

Refractory Epilepsy Special Access Scheme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MGC Pharmaceuticals CEO on the progress of CannEpil & CimetrA (LON:MXC)

MGC Pharmaceuticals CEO on the progress of CannEpil & CimetrA (LON:MXC)

United statesUnited kingdomRoby zomerMgc pharmaceuticalsChief executive officer roby zomerRefractory epilepsy special access scheme

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.